(Q37580837)

21 August 2017

HCMV infection of humanized mice after transplantation of G-CSF-mobilized peripheral blood stem cells from HCMV-seropositive donors (English)

1 reference

stem cell transplantation

21 August 2017

1 reference

Morgan Hakki

1

1 reference

21 August 2017

Devorah C Goldman

2

1 reference

21 August 2017

Daniel N Streblow

3

1 reference

21 August 2017

Kimberly L Hamlin

4

1 reference

21 August 2017

Craig N Krekylwich

5

1 reference

21 August 2017

William H Fleming

6

1 reference

21 August 2017

Jay A Nelson

7

1 reference

21 August 2017

23 October 2013

1 reference

Biology of Blood and Marrow Transplantation

21 August 2017

1 reference

21 August 2017

20

1 reference

21 August 2017

1

1 reference

21 August 2017

132-135

1 reference

Efficiency and risk factors for CMV transmission in seronegative hematopoietic stem cell recipients

21 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922710

Cytomegalovirus: pathogen, paradigm, and puzzle

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922710

Granulocyte-colony stimulating factor reactivates human cytomegalovirus in a latently infected humanized mouse model

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922710

Humanized mice for modeling human infectious disease: challenges, progress, and outlook.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922710

Human cytomegalovirus: Latency and reactivation in the myeloid lineage

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922710

The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922710

Quantitative analysis of latent human cytomegalovirus

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922710

Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922710

Pre-emptive treatment of CMV DNAemia in paediatric stem cell transplantation: the impact of recipient and donor CMV serostatus on the incidence of CMV disease and CMV-related mortality

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922710

High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922710

Cytomegalovirus Infection after Allogeneic Transplantation: Comparison of Cord Blood with Peripheral Blood and Marrow Graft Sources

1 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24161922

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.BBMT.2013.10.019

1 reference

21 August 2017

1 reference

21 August 2017

PubMed publication ID

24161922

1 reference